Hudock Inc’s iShares Biotechnology ETF IBB Stock Holding History

Hudock Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,278	Closed	-$216K	–	204
2025 Q4	$216K	Buy	+1,278	New	+$208K	0.03%	184
2025 Q2	–	Sell	-20,538	Closed	-$2.63M	–	185
2025 Q1	$2.63M	Buy	20,538 +18,804	+1,084%	+$2.55M	0.46%	37
2024 Q4	$229K	Buy	+1,734	New	+$244K	0.04%	152
2023 Q4	–	Sell	-8,910	Closed	-$1.09M	–	156
2023 Q3	$1.09M	Sell	8,910 -174	-2%	-$22.1K	0.26%	48
2023 Q2	$1.15M	Buy	9,084 +1,629	+22%	+$212K	0.27%	49
2023 Q1	$963K	Sell	7,455 -1,120	-13%	-$147K	0.24%	54
2022 Q4	$1.13M	Sell	8,575 -1,048	-11%	-$135K	0.38%	45
2022 Q3	$1.13M	Buy	9,623 +84	+0.9%	+$10.4K	0.38%	46
2022 Q2	$1.12M	Sell	9,539 -1,147	-11%	-$136K	0.38%	46
2022 Q1	$1.39M	Buy	10,686 +5,459	+104%	+$711K	0.39%	42
2021 Q4	$797K	Buy	5,227 +66	+1%	+$10.2K	0.22%	61
2021 Q3	$834K	Buy	5,161 +3	+0.1%	+$505	0.25%	59
2021 Q2	$844K	Sell	5,158 -129	-2%	-$19.9K	0.25%	57
2021 Q1	$796K	Buy	5,287 +13	+0.2%	+$2.06K	0.25%	57
2020 Q4	$799K	Buy	5,274 +298	+6%	+$42.6K	0.26%	53
2020 Q3	$673K	Buy	4,976 +623	+14%	+$84.5K	0.25%	57
2020 Q2	$595K	Buy	4,353 +414	+11%	+$52.8K	0.22%	58
2020 Q1	$424K	Buy	3,939 +308	+8%	+$35.5K	0.17%	66
2019 Q4	$435K	Buy	3,631 +160	+5%	+$17.9K	0.14%	73
2019 Q3	$345K	Sell	3,471 -61	-2%	-$6.38K	0.12%	74
2019 Q2	$385K	Buy	3,532 +424	+14%	+$45.1K	0.14%	69
2019 Q1	$347K	Buy	3,108 +115	+4%	+$12.6K	0.13%	79
2018 Q4	$284K	Sell	2,993 -497	-14%	-$52.8K	0.12%	80
2018 Q3	$425K	Sell	3,490 -149	-4%	-$17.5K	0.16%	67
2018 Q2	$399K	Sell	3,639 -176	-5%	-$18.8K	0.16%	71
2018 Q1	$407K	Sell	3,815 -186	-5%	-$20.6K	0.17%	75
2017 Q4	$427K	Buy	4,001 +2,162	+118%	+$231K	0.19%	62
2017 Q3	$204K	Hold	1,839	–	–	0.1%	82
2017 Q2	$190K	Sell	1,839 -600	-25%	-$59.1K	0.1%	98
2017 Q1	$238K	Sell	2,439 -99	-4%	-$9.48K	0.13%	80
2016 Q4	$224K	Sell	2,538 -2,820	-53%	-$257K	0.13%	88
2016 Q3	$517K	Buy	5,358 +735	+16%	+$69.9K	0.29%	48
2016 Q2	$396K	Buy	4,623 +120	+3%	+$10.8K	0.22%	58
2016 Q1	$391K	Hold	4,503	–	–	0.22%	62
2015 Q4	$507K	Hold	4,503	–	–	0.23%	49
2015 Q3	$455K	Hold	4,503	–	–	0.21%	50
2015 Q2	$553K	Sell	4,503 -225	-5%	-$26.9K	0.25%	46
2015 Q1	$541K	Hold	4,728	–	–	0.24%	47
2014 Q4	$478K	Hold	4,728	–	–	0.22%	54
2014 Q3	$431K	Sell	4,728 -150	-3%	-$13.2K	0.27%	65
2014 Q2	$418K	Buy	4,878 +450	+10%	+$35.5K	0.48%	49
2014 Q1	$349K	Hold	4,428	–	–	0.29%	56
2013 Q4	$335K	Hold	4,428	–	–	0.28%	55
2013 Q3	$309K	Hold	4,428	–	–	0.3%	53
2013 Q2	$257K	Buy	+4,428	New	+$256K	0.38%	60

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hudock Inc's IBB Position: Q1 2026 in Review

Hudock Inc sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 1,278 shares — an estimated $216K sold.

Hudock Inc first reported a position in IBB in Q2 2013 and held it in 45 quarters. The position peaked at $2.63M in Q1 2025. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Hudock Inc reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Hudock Inc sold 1,278 iShares Biotechnology ETF shares in Q1 2026, an estimated $216K.
Hudock Inc first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 45 quarters.
Hudock Inc's iShares Biotechnology ETF position peaked at $2.63M in Q1 2025.
921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Hudock Inc's 13F filing for Q1 2026, filed 13 May 2026.